Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Silvia Bisello"'
Autor:
Andrea Palloni, Silvia Bisello, Ilaria Maggio, Maria Massucci, Andrea Galuppi, Alessandro Di Federico, Alessandro Rizzo, Angela Dalia Ricci, Giambattista Siepe, Alessio Giuseppe Morganti, Giovanni Brandi, Giorgio Frega
Publikováno v:
Current Oncology, Vol 30, Iss 5, Pp 4754-4766 (2023)
(1) Background: Biliary tract cancers (BTCs) are a heterogeneous group of neoplasms with dismal prognosis and the role of adjuvant chemoradiotherapy in high-risk resected patients is unclear. (2) Methods: We retrospectively analyzed the outcomes of B
Externí odkaz:
https://doaj.org/article/a721ba363748424bb0565315716bb2c5
Autor:
Silvia Bisello, Savino Cilla, Anna Benini, Raffaele Cardano, Nam P. Nguyen, Francesco Deodato, Gabriella Macchia, Milly Buwenge, Silvia Cammelli, Tigeneh Wondemagegnehu, A. F. M. Kamal Uddin, Stefania Rizzo, Alberto Bazzocchi, Lidia Strigari, Alessio G. Morganti
Publikováno v:
Current Oncology, Vol 29, Iss 10, Pp 7021-7050 (2022)
Background: The safe use of radiotherapy (RT) requires compliance with dose/volume constraints (DVCs) for organs at risk (OaRs). However, the available recommendations are sometimes conflicting and scattered across a number of different documents. Th
Externí odkaz:
https://doaj.org/article/07daca38e694475286c13df7ad752b9a
Autor:
Silvia Strolin, Miriam Santoro, Giulia Paolani, Ilario Ammendolia, Alessandra Arcelli, Anna Benini, Silvia Bisello, Raffaele Cardano, Letizia Cavallini, Elisa Deraco, Costanza Maria Donati, Erika Galietta, Andrea Galuppi, Alessandra Guido, Martina Ferioli, Viola Laghi, Federica Medici, Maria Ntreta, Natalya Razganiayeva, Giambattista Siepe, Giorgio Tolento, Daria Vallerossa, Alice Zamagni, Alessio Giuseppe Morganti, Lidia Strigari
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundA CE- and FDA-approved cloud-based Deep learning (DL)-tool for automatic organs at risk (OARs) and clinical target volumes segmentation on computer tomography images is available. Before its implementation in the clinical practice, an indep
Externí odkaz:
https://doaj.org/article/ca1a594d36ed41f19e9c81d964c81aa1
Autor:
Giovanna Mantello, Elena Galofaro, Silvia Bisello, Giuditta Chiloiro, Angela Romano, Luciana Caravatta, Maria Antonietta Gambacorta
Publikováno v:
Cancers, Vol 15, Iss 19, p 4838 (2023)
Background: Radiotherapy (RT) plays an important role in the treatment of patients with previously irradiated locally recurrent rectal cancer (LRRC). Over the years, numerous technologies and different types of RT have emerged. The aim of our systema
Externí odkaz:
https://doaj.org/article/d95fb5443bda41cf861a22bb4679dc83
Autor:
Milly BUWENGE, Erica SCIROCCO, Francesco DEODATO, Gabriella MACCHIA, Maria NTRETA, Silvia BISELLO, Giambattista SIEPE, Savino CILLA, Anna Rita ALITTO, Vincenzo VALENTINI, Lidia STRIGARI, Alessio G. MORGANTI, Silvia CAMMELLI
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-8 (2020)
Abstract Background It has been hypothesized that radiotherapy (RT) techniques delivering radiations to larger volumes (IMRT, VMAT) are potentially associated with a higher risk of second primary tumors. The aim of this study was to analyse the impac
Externí odkaz:
https://doaj.org/article/9a9a1f4d6271470aad001f205b532891
Autor:
Alessandra Arcelli, Federica Bertini, Silvia Strolin, Gabriella Macchia, Francesco Deodato, Savino Cilla, Salvatore Parisi, Aldo Sainato, Michele Fiore, Pietro Gabriele, Domenico Genovesi, Francesco Cellini, Alessandra Guido, Silvia Cammelli, Milly Buwenge, Emiliano Loi, Silvia Bisello, Matteo Renzulli, Rita Golfieri, Alessio G. Morganti, Lidia Strigari
Publikováno v:
Cancers, Vol 13, Iss 12, p 3051 (2021)
The study aimed to generate a local failure (LF) risk map in resected pancreatic cancer (PC) and validate the results of previous studies, proposing new guidelines for PC postoperative radiotherapy clinical target volume (CTV) delineation. Follow-up
Externí odkaz:
https://doaj.org/article/8345191a8a024318b12f2c7d0e5c09a6
Autor:
ERIKA GALIETTA, SILVIA STROLIN, SILVIA BISELLO, FRANCESCO CELLINI, LUIGI LOVATO, GLORIA RAVEGNINI, CRISTIAN MARTIGNANI, ALBERTO SPADOTTO, MILLY BUWENGE, SILVIA CAMMELLI, LIDIA STRIGARI, ALESSIO G. MORGANTI, ALESSANDRA ARCELLI
Publikováno v:
In Vivo
The aim of this narrative review of the literature was to collect and analyze the results of the published preclinical studies on stereotactic arrhythmia radioablation (STAR) in the treatment of refractory cardiac arrhythmias. A literature search was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ded4adfa4b92fa92f295689e7082be2d
https://europepmc.org/articles/PMC10188005/
https://europepmc.org/articles/PMC10188005/
Autor:
Federica Medici, Giambattista Siepe, Lidia Strigari, Francesco Massari, Milly Buwenge, Silvia Bisello, Paolo Castellucci, Stefano Fanti, Silvia Cammelli, Alessio Morganti
The aim of the present study was to report the case of a 58-year-old male patient with ureteral carcinoma who underwent ureteroileostomy treatment. At 2 years following surgery, six lymph node metastases (LNMs) were detected in the patient's para-aor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6288f5be7f067c3f5cb8bceb2b2d0b29
https://hdl.handle.net/11585/901178
https://hdl.handle.net/11585/901178
Autor:
Vincenzo Valentini, Gabriella Macchia, M. Ntreta, Milly Buwenge, Silvia Bisello, Anna Rita Alitto, Alessio G. Morganti, Francesco Deodato, Savino Cilla, Naama Dominsky, Giambattista Siepe
Publikováno v:
Anticancer Research. 40:4413-4418
Background/aim To compare the predictive efficacy of National Comprehensive Cancer Network (NCCN) and European Association of Urology (EAU) risk stratification systems in radiotherapy of prostate cancer. Patients and methods One-thousand-nine-hundred
Autor:
Milly, Buwenge, Francesco, Deodato, Naama, Dominsky, Maria, Ntreta, Savino, Cilla, Giambattista, Siepe, Anna Rita, Alitto, Silvia, Bisello, Vincenzo, Valentini, Gabriella, Macchia, Alessio G, Morganti
Publikováno v:
Anticancer research. 40(8)
To compare the predictive efficacy of National Comprehensive Cancer Network (NCCN) and European Association of Urology (EAU) risk stratification systems in radiotherapy of prostate cancer.One-thousand-nine-hundred-nine patients treated with definitiv